NCT04581564

Brief Summary

Every year, approximately 100,000 people are diagnosed with aphasia-a language disorder leading to substantial difficulties in their daily communication. Based on the observation that many people with aphasia can sing words that they otherwise cannot speak, melodic intonation therapy (MIT) was developed in the 1970s. Although recognized as a standard aphasia treatment, the neural mechanisms of MIT have been largely unexplored. Our first goal is to identify the active ingredient of the music intervention. Although rhythm has long been considered secondary to melody, recent evidence has challenged this notion by demonstrating that rhythm alone is sufficient enough to facilitate improvements in speech fluency for people with aphasia. To corroborate the positive role of rhythm, we will train aphasic patients to leverage "rhythmic groove" for sets of sentences/phrases delivered through a fun and engaging video gaming platform. This intervention emerges from the theoretical framework, built from neuroimaging data, that language processes heavily rely on neural resources within the sensorimotor and fronto-striatal circuits that subserve rhythm/timing processes. Our second goal is to characterize the neural plasticity associated with language recovery promoted by the novel rhythm-based therapy. We hypothesize that neuroplasticity will manifest itself as increased white matter tracts, presumably due to changes in myelination in either ipsilateral or contralateral (homologues) language areas. To effectively measure myelin white matter fraction (MWF) in candidate tracts, we will mainly use a patented Laplace-transformed relaxation MRI technique. Additionally, we will measure resting-state functional connectivity using BOLD (Blood Oxygen-Level Dependent) fMRI (functional Magnetic Resonance Imaging). Lastly, we will attempt to record cortical activity using fNIRS (functional Near-Infrared Spectroscopy) during the pre-post behavioral assessments. Taken together, the proposed interdisciplinary research has theoretical, methodological, and clinical innovations and significance. This exploratory work will serve as a critical stepping stone toward unraveling the therapeutic component of music in neurological disorders and will provide evidence-based guidance to the clinicians and therapists.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 9, 2020

Completed
10 months until next milestone

Study Start

First participant enrolled

August 6, 2021

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2024

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

July 14, 2025

Completed
Last Updated

July 14, 2025

Status Verified

June 1, 2025

Enrollment Period

2.6 years

First QC Date

August 28, 2020

Results QC Date

November 20, 2024

Last Update Submit

June 25, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Aphasia Spoken Word Assessment

    Participants will be evaluated on practiced spoken words. The mean difference of practiced spoken words before and after the intervention will be calculated.

    10 weeks

  • Western Aphasia Battery (WAB) Test

    Participants' language ability will be assessed with Western Aphasia Battery (WAB), whose reliability and validity have been well established. The mean difference before and after the intervention will be calculated. The Aphasia Quotient is scored on a scale of 0-100. Lower scores represent more severe aphasia and higher scores represent lesser aphasia severity.

    10 weeks

Study Arms (2)

Rhythm intervention

EXPERIMENTAL

Practice speech production daily through rhythmic activity

Behavioral: Rhythm-based speech therapy app (i.e., Speech Hero)

Non-rhythm intervention

ACTIVE COMPARATOR

Conventional speech production therapy without the use of rhythmic activities

Behavioral: Non-rhythm based (singing) application (conventional speech therapy)

Interventions

Participants will be issued a tablet device pre-installed with a rhythm-based application. They will initially be given a tutorial on how to use the application and encouraged to use application on a daily basis but at the least 5 times a week.

Rhythm intervention

Participants will be issued a tablet device pre-installed with a singing-based application. They will initially be given a tutorial on how to use the application and encouraged to use application on a daily basis but at the least 5 times a week.

Non-rhythm intervention

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be over six months post-stroke
  • Limb motor function, at least on the left side, should remain relatively intact
  • Be able to name at least few items
  • Must not suffer from any other type of neurological disease.

You may not qualify if:

  • less than six months post-stroke
  • Metal in the body
  • Comorbidity with other neurological disorders (e.g., depression)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yune S Lee

Richardson, Texas, 75080, United States

Location

MeSH Terms

Conditions

Aphasia

Interventions

Singing

Condition Hierarchy (Ancestors)

Speech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PhonationRespiratory Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Limitations and Caveats

The procedures specified in the protocol were determined to be non-compliant by the IRB (Institutional Review Board) and the deviations may have compromised integrity of the data collected and analyzed.

Results Point of Contact

Title
Dr. Yune Lee
Organization
Assistant Professor. Speech, Language and Hearing

Study Officials

  • Yune Lee, PhD

    UT Dallas

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The intervention is administered using an app installed in a smart phone or tablet personal computer. It does not involve drug, etc.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2020

First Posted

October 9, 2020

Study Start

August 6, 2021

Primary Completion

February 28, 2024

Study Completion

February 28, 2024

Last Updated

July 14, 2025

Results First Posted

July 14, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

No individual participant data (IPD) will be shared

Locations